tiprankstipranks
Trending News
More News >
Alpha Cognition Inc (ACOG)
NASDAQ:ACOG
US Market
Advertisement

Alpha Cognition Inc (ACOG) Earnings Dates, Call Summary & Reports

Compare
20 Followers

Earnings Data

Report Date
Apr 07, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.26
Last Year’s EPS
-0.13
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive momentum with significant growth in ZUNVEYL sales and market engagement, supported by a solid financial position. However, challenges such as operating losses and limited payer coverage remain.
Company Guidance
During the third quarter of 2025, Alpha Cognition reported significant progress with their Alzheimer's treatment, ZUNVEYL. Sales of ZUNVEYL experienced robust growth, with ex-factory purchases increasing by 44% from 2,640 to 3,808 bottles compared to the previous quarter, and demand sales bottles dispensed growing by 102%. The company engaged with over 1,850 prescribers, leading to prescriptions being written in over 500 nursing homes, with 70% of these homes seeing repeat prescriptions. Total revenue for the quarter was $2.8 million, comprised of $2.3 million from net product sales and $507,000 from licensing revenue. Despite an operating loss of $5.3 million, improvements in fair value of derivative liabilities and interest income helped reduce the net loss to $1.3 million. The company also managed to raise $38 million in October, strengthening their balance sheet and extending their operational runway into 2027. Looking ahead, Alpha Cognition expects continued growth in ZUNVEYL sales as they expand market access, and they anticipate full-year operating expenses for 2025 to be between $28 million and $30 million, a decrease from prior guidance due to cost discipline and operational efficiency.
Sales Growth of ZUNVEYL
The third quarter of 2025 saw a significant increase in sales for ZUNVEYL, with ex-factory purchases rising 44% quarter-over-quarter and demand sales bottles dispensed growing by 102% from Q2.
Successful Engagement in Long-Term Care Market
Alpha Cognition engaged 2,038 homes in Q3, bringing the total reach to 2,942 unique homes, with 70% of those homes placing repeat orders.
Positive Clinical Feedback
ZUNVEYL has shown good clinical performance with reports of cognition improvement and limited adverse events, maintaining a low single-digit rate of GI adverse events.
Strong Financial Position
The company raised $38 million in net proceeds through an equity offering, extending their operational runway into 2027.
Progress in Research and Development
Alpha Cognition plans to initiate two studies, CONVERGE and BEACON, to assess ZUNVEYL's cognitive benefits and tolerability, with completion expected in late 2026.

Alpha Cognition Inc (ACOG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ACOG Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 07, 2026
2025 (Q4)
-0.26 / -
-0.13
Nov 13, 2025
2025 (Q3)
-0.43 / -0.08
-0.3174.19% (+0.23)
Aug 14, 2025
2025 (Q2)
-0.46 / -0.65
-0.25-160.00% (-0.40)
May 15, 2025
2025 (Q1)
- / -
-0.75
Mar 31, 2025
2024 (Q4)
-0.58 / -0.13
-0.7582.67% (+0.62)
Nov 15, 2024
2024 (Q3)
-1.00 / -0.31
-0.7558.67% (+0.44)
Aug 12, 2024
2024 (Q2)
-1.00 / -0.25
-0.7566.67% (+0.50)
May 14, 2024
2024 (Q1)
- / -
-0.5
Apr 03, 2024
2023 (Q4)
- / -0.75
-0.5-50.00% (-0.25)
Nov 28, 2023
2023 (Q3)
- / -0.75
-125.00% (+0.25)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ACOG Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$6.13$5.94-3.10%
Aug 14, 2025
$9.99$8.00-19.92%
May 15, 2025
$6.86$6.81-0.73%
Mar 31, 2025
$5.53$5.06-8.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alpha Cognition Inc (ACOG) report earnings?
Alpha Cognition Inc (ACOG) is schdueled to report earning on Apr 07, 2026, After Close (Confirmed).
    What is Alpha Cognition Inc (ACOG) earnings time?
    Alpha Cognition Inc (ACOG) earnings time is at Apr 07, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ACOG EPS forecast?
          ACOG EPS forecast for the fiscal quarter 2025 (Q4) is -0.26.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis